These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 22943271)
1. Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness. Leshem E; Caine Y; Rosenberg E; Maaravi Y; Hermesh H; Schwartz E J Travel Med; 2012; 19(5):308-10. PubMed ID: 22943271 [TBL] [Abstract][Full Text] [Related]
2. Acclimatizing with acetazolamide. Basnyat B J Travel Med; 2012; 19(5):281-3. PubMed ID: 22943266 [No Abstract] [Full Text] [Related]
3. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness. Kayser B; Hulsebosch R; Bosch F High Alt Med Biol; 2008; 9(1):15-23. PubMed ID: 18331216 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912 [TBL] [Abstract][Full Text] [Related]
5. Acetazolamide or not, prior to ascent? DeLellis SM J Spec Oper Med; 2010; 10(4):38-40. PubMed ID: 21442590 [TBL] [Abstract][Full Text] [Related]
6. Age is no barrier to success at very high altitudes. Stokes S; Kalson NS; Earl M; Whitehead AG; Tyrrell-Marsh I; Frost H; Davies A Age Ageing; 2010 Mar; 39(2):262-5. PubMed ID: 20068217 [No Abstract] [Full Text] [Related]
7. [Your patient wants to go to the mountains. You protect him from mountain sickness and altitude edema]. MMW Fortschr Med; 2005 Apr; 147(14):4-5. PubMed ID: 15887670 [No Abstract] [Full Text] [Related]
8. Low-dose acetylsalicylic Acid analog and acetazolamide for prevention of acute mountain sickness. Basnyat B; Gertsch JH; Holck PC High Alt Med Biol; 2008; 9(4):349; author reply 351-2. PubMed ID: 19115924 [No Abstract] [Full Text] [Related]
9. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. Basnyat B; Gertsch JH; Holck PS; Johnson EW; Luks AM; Donham BP; Fleischman RJ; Gowder DW; Hawksworth JS; Jensen BT; Kleiman RJ; Loveridge AH; Lundeen EB; Newman SL; Noboa JA; Miegs DP; O'Beirne KA; Philpot KB; Schultz MN; Valente MC; Wiebers MR; Swenson ER High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963 [TBL] [Abstract][Full Text] [Related]
10. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m). Carlsten C; Swenson ER; Ruoss S High Alt Med Biol; 2004; 5(1):33-9. PubMed ID: 15072715 [TBL] [Abstract][Full Text] [Related]
11. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Richalet JP; Larmignat P; Poitrine E; Letournel M; Canouï-Poitrine F Am J Respir Crit Care Med; 2012 Jan; 185(2):192-8. PubMed ID: 22071330 [TBL] [Abstract][Full Text] [Related]
12. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT). Gertsch JH; Lipman GS; Holck PS; Merritt A; Mulcahy A; Fisher RS; Basnyat B; Allison E; Hanzelka K; Hazan A; Meyers Z; Odegaard J; Pook B; Thompson M; Slomovic B; Wahlberg H; Wilshaw V; Weiss EA; Zafren K Wilderness Environ Med; 2010 Sep; 21(3):236-43. PubMed ID: 20832701 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711 [TBL] [Abstract][Full Text] [Related]
14. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness. Lipman GS; Jurkiewicz C; Winstead-Derlega C; Navlyt A; Burns P; Walker A; Phillips C; Reilly A; Burnier A; Romero J; Warner K; Hackett P High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608 [No Abstract] [Full Text] [Related]
15. Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide. Bärtsch P; Schneider M BMJ; 2001 Jan; 322(7277):48-9. PubMed ID: 11141168 [No Abstract] [Full Text] [Related]
16. Efficacy of low-dose acetazolamide for the prophylaxis of acute mountain sickness. Dumont L; Tramer MR; Lysakowski C; Mardirosoff C; Kayser B High Alt Med Biol; 2003; 4(3):399; author reply 400. PubMed ID: 14561245 [No Abstract] [Full Text] [Related]
17. Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story. Swenson ER; Teppema LJ J Appl Physiol (1985); 2007 Apr; 102(4):1305-7. PubMed ID: 17194729 [No Abstract] [Full Text] [Related]
18. Altitude illness: risk factors, prevention, presentation, and treatment. Fiore DC; Hall S; Shoja P Am Fam Physician; 2010 Nov; 82(9):1103-10. PubMed ID: 21121556 [TBL] [Abstract][Full Text] [Related]
19. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. Low EV; Avery AJ; Gupta V; Schedlbauer A; Grocott MP BMJ; 2012 Oct; 345():e6779. PubMed ID: 23081689 [TBL] [Abstract][Full Text] [Related]
20. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis. Ritchie ND; Baggott AV; Andrew Todd WT J Travel Med; 2012; 19(5):298-307. PubMed ID: 22943270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]